A detailed history of Lazard Asset Management LLC transactions in Renalytix PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 681 shares of RNLX stock, worth $143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
681
Previous 125,478 99.46%
Holding current value
$143
Previous $107,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.23 - $0.93 $28,703 - $116,061
-124,797 Reduced 99.46%
681 $0
Q1 2024

May 14, 2024

SELL
$0.26 - $1.47 $2,896 - $16,378
-11,142 Reduced 8.16%
125,478 $104,000
Q4 2023

Feb 14, 2024

SELL
$0.33 - $1.61 $1,016 - $4,958
-3,080 Reduced 2.2%
136,620 $53,000
Q3 2023

Nov 14, 2023

SELL
$1.51 - $4.01 $6,387 - $16,962
-4,230 Reduced 2.94%
139,700 $223,000
Q2 2023

Aug 14, 2023

SELL
$2.0 - $2.92 $278 - $405
-139 Reduced 0.1%
143,930 $420,000
Q1 2023

May 15, 2023

BUY
$1.93 - $3.72 $2,451 - $4,724
1,270 Added 0.89%
144,069 $348,000
Q4 2022

Feb 14, 2023

SELL
$1.06 - $2.21 $129,530 - $270,059
-122,199 Reduced 46.11%
142,799 $267,000
Q3 2022

Nov 14, 2022

BUY
$1.19 - $2.78 $16,466 - $38,466
13,837 Added 5.51%
264,998 $339,000
Q2 2022

Aug 09, 2022

BUY
$2.45 - $7.81 $211,542 - $674,346
86,344 Added 52.39%
251,161 $615,000
Q1 2022

May 13, 2022

BUY
$5.88 - $15.9 $228,684 - $618,382
38,892 Added 30.89%
164,817 $1.14 Million
Q4 2021

Feb 09, 2022

BUY
$13.43 - $27.4 $873,514 - $1.78 Million
65,042 Added 106.83%
125,925 $2 Million
Q3 2021

Nov 15, 2021

BUY
$17.91 - $34.78 $51,312 - $99,644
2,865 Added 4.94%
60,883 $1.22 Million
Q2 2021

Aug 12, 2021

BUY
$23.56 - $34.25 $1.35 Million - $1.96 Million
57,119 Added 6353.62%
58,018 $1.79 Million
Q1 2021

May 14, 2021

BUY
$15.25 - $31.13 $13,709 - $27,985
899 New
899 $23,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $7.86M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.